Citing COVID-19 disruptions, STAAR Surgical (NASDAQ:STAA) is withdrawing its outlook for fiscal 2020.
STAAR expects Q1 total net sales to be ~$34.9M, up ~7% Y/Y.
COVID-19 negatively impacted Q1 sales by ~$4M.
Q1 ICL unit growth is expected to be up ~9%.
The company expects to report complete Q1 financial results on or about May 6.
https://seekingalpha.com/news/3560075-staar-surgical-pulls-2020-guidance-amid-covidminus-19
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.